$682,000 in Duke Energy Grants Provide Economic Boost to Florida Communities
Duke Energy and the Duke Energy Foundation are investing $682,000 in grants to support 35 local economic development agencies and businesses dedicated to bringing new jobs and investment in Florida. This year’s funding will allow the University of Florida (UF Innovate | Accelerate) to identify and vet promising biotechnology businesses seeking to scale, with potential to relocate in the city of Gainesville and city of Alachua area.
Hack #9| Entrepreneurship is Boundaryless
#9 Hack of The Week emphasizes the importance of collaboration, global networking, and embracing the entrepreneurial ecosystem to foster innovation and resilience. It highlights real-world examples, such as the rental umbrella service in Tokyo and the airport operations industry's successful recovery after the COVID-19 pandemic.
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of 'Post COVID Syndrome (AKA "Long Haul COVID Syndrome").
Tech Tuesday: Oneness Technologies
In this week's Tech Tuesday featured on WCJB TV20, we interview Dr. Neha Chavan and Alex Blanton from Oneness Technologies, a biotech company that combines cutting-edge scientific expertise with a plant-based medicine approach. The startup's technology revolutionizes the health and wellness industry by ensuring maximum absorption of hemp products in the body, minimizing wastage, and reducing side effects.
You’re More Than the Phone in Your Hand: Entrepreneurial Hack of the Week
In a world where technology reigns supreme, concerns about AI's threat to jobs and the erosion of human relationships have reached a tipping point. But what if there's a genius hack to strike the perfect balance? In this thought-provoking article, Karl LaPan, Director of UF Innovate Accelerate, unravels the intricate relationship between technology, AI, and our fundamental need for genuine human connection.
MLM Biologics Developing Wound Infection Prevention Device for Military
MLM Biologics Inc., a graduate company of Sid Martin Biotech, has been awarded nearly $1.5 million by the US Army to develop a device that prevents infection in battlefield wounds. The device will utilize MLM Biologic's collagen processing and stabilization technologies. The focus is on preventing infection in complex, traumatic injuries in austere environments. The company plans to incorporate their proprietary technologies and proven anti-inflammatory and anti-microbial components, with potential civilian use in the future.
Lacerta and Prevail, a Wholly Owned Subsidiary of Lilly, Sign Agreement To Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company. The collaboration will focus on the discovery and development of novel AAV capsids for CNS diseases.
Admiral Named One of the Fastest Growing Companies in U.S.
The UF Innovate | Accelerate resident client Admiral also ranked as Top 100 (75) of Marketing and Advertising companies, Top 100 (90) from the state of Florida, and the #1 fastest growing company from its hometown of Gainesville, FL
Why Aren’t Digital Pills Taking Off?
In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The enthusiasm for digital approaches involving sensors, apps, and wearables that could transmit information across systems, commonly grouped under the term Internet of Things, also spread. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. Privacy and logistical concerns, especially while studying such applications for vulnerable populations, have lingered.
The Emerging Field of Regenerative Medicine: Personalized, Precision Medicine
Regenerative medicine, in conjunction with personalized medicine, is responsible for the next major paradigm shift in modern medicine. However, neither regenerative nor personalized precision medicine are subjects traditionally found in the curriculum of U.S. medical schools. As such, this emergence has been met with skepticism, doubt and confusion.
